|
2022
|
Invention
|
Reverse amide-linked melanocortin receptor-specific cyclic peptides.
Melanocortin receptor-speci... |
|
|
Invention
|
Diamine-linked melanocortin receptor-specific cyclic peptides for ocular indications.
Melanocort... |
|
|
Invention
|
Orally active melanocortin receptor-4 compounds.
A compound of the formula
A compound of the f... |
|
2021
|
G/S
|
Pharmaceutical preparations for the treatment of sexual dysfunction and sexual disorders; pharmac... |
|
|
Invention
|
Reverse amide-linked melanocortin receptor-specific cyclic peptides. Melanocortin receptor-specif... |
|
|
Invention
|
Diamine-linked receptor-specific cyclic peptides. Receptor-specific cyclic peptides of the formul... |
|
2020
|
Invention
|
Melanocortin receptor-specific peptide formulations and methods for gastrointestinal tract-specif... |
|
|
Invention
|
Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy. Methods pr... |
|
|
Invention
|
Therapies for obesity, diabetes and related indications.
The invention relates to methods, uses,... |
|
2019
|
Invention
|
Orally active melanocortin receptor-4 compounds. 123456a6b 6b are as defined in the specification... |
|
|
Invention
|
Melanocortin receptor-specific peptides. Melanocortin receptor-specific cyclic peptides of the fo... |
|
2018
|
Invention
|
Melanocortin receptor-specific peptide with c-terminal naphthylalanine. Melanocortin receptor-spe... |
|
2017
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of sexual dysfunction ... |
|
|
Invention
|
Therapies for obesity, diabetes and related indications. The invention relates to methods, uses, ... |
|
|
Invention
|
Melanocortin-1 receptor-specific linear peptides. 6 are as defined in the specification, composit... |
|
2016
|
Invention
|
Replacement therapy for natriuretic peptide deficiencies.
Use and methods of use of natriuretic ... |
|
|
Invention
|
Melanocortin-1 receptor-specific cyclic hexapeptides. Melanocortin receptor-specific cyclic hexap... |
|
2015
|
Invention
|
Replacement therapy for natriuretic peptide deficiencies. Use and methods of use of natriuretic p... |
|
2014
|
Invention
|
Melanocortin-1 receptor-specific linear peptides. Melanocortin receptor-specific linear peptides ... |
|
|
Invention
|
Melanocortin-1 receptor-specific cyclic peptides. Melanocortin receptor-specific cyclic peptides ... |
|
|
Invention
|
Melanocortin receptor-specific heptapeptides. 7 and Y are as defined in the specification, compos... |
|
2013
|
Invention
|
Bremelanotide therapy for female sexual dysfunction. Use of a subcutaneously administered dose of... |
|
|
Invention
|
Melanocortin receptor-specific peptides for treatment of female sexual dysfunction. Methods for u... |
|
2012
|
Invention
|
Uses of natriuretic peptide constructs. Use of constructs which bind to one or more natriuretic p... |
|
2011
|
Invention
|
Lactam-bridged melanocortin receptor-specific peptides. Lactam-bridged melanocortin receptor-spec... |
|
|
Invention
|
Peptidic constructs with amino acid surrogates.
Peptidic constructs including at least one ring-... |
|
|
Invention
|
Melanocortin receptor-specific spiro-piperidine compounds. Melanocortin receptor-specific compoun... |
|
2010
|
Invention
|
Melanocortin receptor-specific peptides for treatment of sexual dysfunction. A melanocortin recep... |
|
2009
|
Invention
|
Amine substituted piperidine melanocortin receptor-specific compounds. A compound of the formula ... |
|
2006
|
Invention
|
N-alkylated cyclic peptide melanocortin agonists. A melanocortin-4 receptor agonist cyclic peptid... |
|
|
Invention
|
Linear melanocortin receptor-specific peptides for cachexia. Linear peptides with a C-terminus —O... |
|
1997
|
G/S
|
biotechnological research and developmental services |
